ResearcherSapporo Medical UniversityActive in the last 2 years
Kohichi Takada
Matched on ORCID iD 0000-0002-1393-9442; OpenAlex author ID A5052282410. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 14
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: none · 2026: 2 papers
Papers 7
- Perioperative prognostic factors of early recurrence in resectable pancreatic ductal adenocarcinoma following neoadjuvant chemotherapy: A retrospective multice… Last author DOI 10.21203/rs.3.rs-9156519/v1↗
- Warm Autoimmune Hemolytic Anemia Associated with Pancreatic Adenocarcinoma Showing Ectopic Expression of Band 3 Protein: A Case Report. Co-author DOI 10.2169/internalmedicine.6765-25↗
- Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter prospective study. Last author DOI 10.1093/jjco/hyad131↗
- Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. Last author DOI 10.1111/cas.16101↗
- Pancreatic cancer with leptomeningeal carcinomatosis: case report and literature review. Co-author DOI 10.1007/s13691-020-00405-7↗
- FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells. Co-author DOI 10.1097/mpa.0000000000001462↗
- Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach. Co-author DOI 10.1371/journal.pone.0039545↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Makoto Yoshida · 4 shared papers, 2020–2026 · strength 0.86
- Paper Warm Autoimmune Hemolytic Anemia Associated with Pancreatic Adenocarcinoma Showing Ectopic Expression of Band 3 Protein… DOI 10.2169/internalmedicine.6765-25↗
- Paper Perioperative prognostic factors of early recurrence in resectable pancreatic ductal adenocarcinoma following neoadjuva… DOI 10.21203/rs.3.rs-9156519/v1↗
- Paper Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter pro… DOI 10.1093/jjco/hyad131↗
- Joji Muramatsu · 3 shared papers, 2024–2026 · strength 0.63
- Paper Perioperative prognostic factors of early recurrence in resectable pancreatic ductal adenocarcinoma following neoadjuva… DOI 10.21203/rs.3.rs-9156519/v1↗
- Paper Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. DOI 10.1111/cas.16101↗
- Paper Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter pro… DOI 10.1093/jjco/hyad131↗
- Masayoshi Kobune · 4 shared papers, 2012–2026 · strength 0.61
- Paper Warm Autoimmune Hemolytic Anemia Associated with Pancreatic Adenocarcinoma Showing Ectopic Expression of Band 3 Protein… DOI 10.2169/internalmedicine.6765-25↗
- Paper Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. DOI 10.1111/cas.16101↗
- Paper FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells. DOI 10.1097/mpa.0000000000001462↗
- Tomohiro Kubo · 3 shared papers, 2020–2024 · strength 0.48
- Paper Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. DOI 10.1111/cas.16101↗
- Paper Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter pro… DOI 10.1093/jjco/hyad131↗
- Paper Pancreatic cancer with leptomeningeal carcinomatosis: case report and literature review. DOI 10.1007/s13691-020-00405-7↗
- Makoto Yoshida · 3 shared papers, 2012–2024 · strength 0.31
- Paper Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. DOI 10.1111/cas.16101↗
- Paper FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells. DOI 10.1097/mpa.0000000000001462↗
- Paper Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach. DOI 10.1371/journal.pone.0039545↗
- Akari Goto · 1 shared paper, 2026 · strength 0.30
- Yuki Ikeda · 2 shared papers, 2020–2024 · strength 0.29
- Makoto Usami · 2 shared papers, 2020–2024 · strength 0.27
- Masafumi Imamura · 1 shared paper, 2026 · strength 0.26
- Takashi Kojima · 1 shared paper, 2024 · strength 0.19
- Takumi Konno · 1 shared paper, 2024 · strength 0.19
- Junji Kato · 2 shared papers, 2012–2020 · strength 0.15
- Junji Kato · 1 shared paper, 2020 · strength 0.10
- Tsuyoshi Hayashi · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.